The pharmacy partner built for the demands of modern telehealth.

Strive is a licensed 503A compounding pharmacy. That means every compound we prepare is based on a valid, patient-specific prescription from a licensed prescriber — the model that aligns directly with telehealth's personalized care approach. Our 503A status is paired with voluntary NABP, PCAB/ACHC, and LegitScript accreditations in addition to the standard compliance floor.

We hold active pharmacy licenses across all 50 states. Your account representative will confirm licensing in your specific markets during discovery — before you build any program around geographic assumptions.

Our list of compounded medications is built around the regimens telehealth platforms are built around: weight management, hormone support, longevity, sexual wellness, hair health, skincare, and beyond. A full list of commonly prescribed compounded medications is available upon request, and your account representative will confirm which specific formulations are available in your active states.

We discuss pricing transparently early in the conversation so your team has the information needed to plan your program. As your patient volume grows and you add service lines, your pricing reflects that growth. Your account representative will walk through the full tier structure and what scaling looks like for your specific program.

Temperature-sensitive compounds — including injectables — ship with validated cold-chain packaging to maintain integrity from our facility to your patient's door. Packaging is appropriate to the compound, the transit time, and the destination climate.

Turnaround timelines vary by formulation, and we provide a clear fulfillment service level agreement upfront for your most-used compounds. Your team will have consistent windows to communicate to patients at enrollment — not estimates that shift week to week.

It's the right question to ask, and we expect it. Fill rate consistency at scale is part of every discovery conversation we have with telehealth partners. We're transparent about our current throughput, what your growth trajectory looks like relative to that, and where the natural scaling thresholds are. If we can't support where you're headed, we'll tell you directly.

When possible, your account representative reaches out before your patients are affected — with a plain-language summary of the situation, projected resolution timeline, and any available alternatives.

We support API-based prescription intake for platforms operating at scale, and work with your technical team to establish a workflow that minimizes manual touchpoints. For platforms in earlier integration stages, structured eRx and portal-based processes are available while a deeper connection is built. The goal in either case is a prescription-to-fulfillment handoff that's as close to invisible as possible.

Patients receive tracked shipments with visibility throughout the delivery process. Shipping notifications and status updates are part of the standard fulfillment flow — your patients aren't left guessing, and your team isn't fielding status calls. For platforms with specific patient communication requirements, we can align the notifications and delivery experience with your standards.

We follow standard 503A pharmacy labeling requirements. Any additional customized packaging considerations may be discussed during onboarding within the constraints of 503A compounding practice. Your account representative and onboarding team can walk through what's possible for your program.

Everything your compliance team will ask for: NABP and PCAB/ACHC accreditation certificates, LegitScript certification, active pharmacy licenses by state, certificates of analysis for all active ingredients, batch testing records, and full API sourcing documentation. We provide this proactively — organized and current — so your team isn't chasing it down.

Strive monitors FDA guidance, state board updates, and USP standards continuously. Active pharmaceutical ingredients (APIs) used in our GLP-1 compounded medications come exclusively from FDA-published Green List facilities that meet applicable inspection and compliance standards. When a regulatory change affects a formulation in your active formulary, we work to get ahead of it with direct notification, a plain-language summary, and recommended action — before it becomes a problem for your patients or your program.

Most telehealth partners reach go-live within 2–3 weeks from a signed agreement. The majority of that timeline is your team's internal compliance review and technical integration setup. Our onboarding configuration and account setup typically takes 3–5 business days. Your account representative sets a clear go-live target at the start of onboarding and tracks against it.

Every partner gets a dedicated account representative — not a support queue. You have a direct line to someone who knows your platform, your patient population, and your history with us. Our approach is proactive: we reach out when things change rather than waiting for you to surface a problem. As your platform grows, your account representative scales the relationship with you.